Test Price
2,800 AED✅ Home Collection Available
SLC34A1 Gene Fanconi Renotubular Syndrome Type 2 Genetic Test in UAE
Executive Summary & Core Metrics
- Accuracy Guarantee: 99.9% diagnostic sensitivity via ISO 9001:2015 certified NGS processing.
- Pre-Test Genetic Counselling: Mandatory pedigree-chart session ensuring informed consent, included with booking.
- Premium Logistics: VIP Mobile Phlebotomy and temperature-controlled cold-chain home collection, available daily from 8 AM to 11 PM.
- Clinical Guidance: Complimentary telephonic post-test clinical guidance by a DHA-licensed consultant medical geneticist for result interpretation.
- Insurance Support: Direct billing verification and pre-authorization assistance via WhatsApp at +971 54 548 8731.
Test Overview & Methodology
The SLC34A1 Gene Fanconi Renotubular Syndrome Type 2 Genetic Test is a comprehensive molecular assay that sequences the entire coding region of the SLC34A1 gene to diagnose hereditary Fanconi renotubular syndrome type 2 (FRTS2), an autosomal recessive renal tubular disorder. This definitive diagnosis enables targeted clinical management, informed family screening, and appropriate genetic counselling.
| Parameter | Our Test (UAE Leading Lab) | Closest Alternative |
|---|---|---|
| Precision | NGS with greater than 99.9% analytical sensitivity and specificity | Sanger sequencing limited to targeted mutation hotspots |
| Methodology | Next Generation Sequencing (Illumina Platform) with reflex MLPA if required | Single exon PCR and Sanger, may miss copy number variants |
| Turnaround Time | 3 to 4 weeks | 6 to 8 weeks with international shipping |
| Regulatory Compliance | DHA Licensed, ISO 9001:2015 (Cert: INT/EGQ/2509DA/3139), UAE PDPL | May lack UAE-specific data privacy compliance |
Physician Insight & Safety Protocols
"As a consultant medical geneticist, I recognise the complex emotional journey that accompanies genetic testing for a hereditary renal condition. The SLC34A1 gene analysis provides a precise molecular diagnosis, yet every result must be interpreted within the full context of the patient's clinical presentation, electrolyte profile, and three-generation family pedigree. Patients should never modify or discontinue prescribed therapies without direct supervision from their treating nephrologist or primary physician."
— Lina Osama Zaki Quteineh, Consultant Medical Genetics, DHA Registration ID: 9294403
Therapeutic Advisory
⚠️ Do Not Alter Prescribed Medications
Maintain all current medications and supplements exactly as directed by your treating clinician. The genetic testing process does not replace or supersede active medical management. Consult your physician before making any changes to your therapeutic regimen.
Safety Exclusion and Emergency Red Flags
Contraindications and Urgent Warning Signs
- Exclusion Criteria: Individuals unable to provide informed consent, active coagulopathy contraindicating venipuncture, or ongoing acute illness that may confound baseline electrolyte and renal function interpretation.
- Emergency Red Flags: Sudden severe flank pain, profound muscle weakness, confusion, seizures, signs of severe dehydration, or rapid electrolyte imbalance require immediate emergency medical attention without waiting for genetic test results.
Patient FAQ & Clinical Guidance
1. What is the SLC34A1 genetic test and why is it performed?
The SLC34A1 NGS test detects pathogenic mutations that cause Fanconi renotubular syndrome type 2. It is performed to confirm a genetic diagnosis of this autosomal recessive renal tubular disorder, enabling targeted treatment plans, appropriate electrolyte monitoring, and cascade screening for at-risk family members.
2. How is the sample collected and what is the turnaround time?
A certified phlebotomist collects a peripheral whole blood sample at your home between 8 AM and 11 PM daily. The specimen is transported under temperature-controlled cold-chain logistics to our ISO-accredited laboratory. NGS analysis and comprehensive variant interpretation are completed within 3 to 4 weeks.
3. Do I need a physician referral and is the test covered by insurance?
A referral from a general practitioner, nephrologist, or clinical geneticist is strongly recommended to maximise insurance reimbursement eligibility. Our dedicated team verifies your coverage and facilitates direct billing via WhatsApp at +971 54 548 8731 prior to sample collection.
4. Will I receive genetic counselling with this test?
Yes, pre-test genetic counselling with a pedigree-chart session is included as a mandatory component of the service to ensure informed consent. A complimentary telephonic post-test consultation with a DHA-licensed consultant medical geneticist is also provided to explain your results and guide next steps.
UAE Regulatory & Data Privacy Adherence
🏛️ Regulatory Compliance Framework
- Data Protection: Fully compliant with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL), governing the collection, processing, storage, and transfer of personal health data within the UAE.
- Health Information Governance: Aligned with Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields, ensuring secure handling of electronic medical records and telehealth communications.
- Medical Liability and Patient Consent: Adheres to Federal Decree-Law No. 4 of 2016 on Medical Liability, guaranteeing that all genetic testing procedures are performed with verified informed consent and full accountability for clinical safety.
- DHA Licensing and Oversight: The laboratory operates under DHA Facility License No. 1143 and is subject to regular audit and inspection by the Dubai Health Authority and Ministry of Health and Prevention.
Clinical & Logistical Metadata
| Test Name | SLC34A1 Gene Fanconi Renotubular Syndrome Type 2 Genetic Test |
| Price (AED) | 2,800 AED |
| Turnaround Time | 3 to 4 weeks |
| Sample Type / Matrix | Peripheral whole blood (3-5 mL in EDTA tube), extracted DNA, or FTA card |
| Methodology Used | Next Generation Sequencing (NGS) on Illumina Platform with Sanger confirmation and reflex MLPA for copy number variant detection |
| ICD-10-CM Code | N15.1 |
| LOINC Code | 81322-0 |
| DHA Facility License & Laboratory Address | License No. 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians